Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction

被引:119
作者
Manten, Gwendolyn T. R.
Sikkema, Marko J.
Voorbij, Hieronymus A. M.
Visser, Gerard H. A.
Bruinse, Hein W.
Franx, Arie
机构
[1] Univ Med Ctr Utrecht, Dept Perinatol & Gynecol, NL-3508 AB Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Clin Chem, NL-3508 AB Utrecht, Netherlands
[3] St Elizabeth Hosp, Dept Obstet & Gynecol, Tilburg, Netherlands
关键词
pregnancy; preeclampsia; intrauterine growth restriction; lipoprotein (a); cardiovascular risk factors;
D O I
10.1080/10641950601146574
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Women with a history of preeclampsia or intrauterine growth restriction (IUGR) have an increased risk for cardiovascular disease in later life. We determined the presence of traditional and novel risk factors for cardiovascular disease in these women. Methods: We studied 256 women with a history of preeclampsia and 59 women with a history of intrauterine growth restriction. Fifty-three women with a history of uncomplicated pregnancy served as controls. We determined values for blood pressure, body mass index, concentrations of cholesterol, high-density lipoprotein cholesterol, triglycerides and lipoprotein (a), and insulin resistance. Results: Women with a history of preeclampsia exhibited more risk factors for future cardiovascular disease such as dyslipidemia, hypertension, obesity, and increased insulin resistance compared with women with a history of uncomplicated pregnancy. Women with a history of IUGR have higher concentrations of cholesterol and show a tendency to higher BMI, higher triglyceride concentrations, and increased insulin resistance as compared with women with a history of normal pregnancy. Conclusions: Preeclampsia or IUGR may represent an early marker for increased risk for early cardiovascular disease.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 35 条
[1]  
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5
[2]   The elevated plasma lipoprotein(a) concentrations in preeclampsia do not precede the development of the disorder [J].
Bar, J ;
Harell, D ;
Bardin, R ;
Pardo, J ;
Chen, R ;
Hod, M ;
Sullivan, M .
THROMBOSIS RESEARCH, 2002, 105 (01) :19-23
[3]   Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? [J].
Barden, AE ;
Beilin, LJ ;
Ritchie, L ;
Walters, BN ;
Michael, C .
JOURNAL OF HYPERTENSION, 1999, 17 (09) :1307-1315
[4]  
Barker D.J. P., 1994, MOTHERS BABIES DIS L
[5]  
BERG K, 1994, CLIN GENET, V46, P52
[6]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[7]   LP(A) LIPOPROTEIN IN CARDIOVASCULAR-DISEASE [J].
DAHLEN, GH .
ATHEROSCLEROSIS, 1994, 108 (02) :111-126
[8]   Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies [J].
Danesh, J ;
Collins, R ;
Peto, R .
CIRCULATION, 2000, 102 (10) :1082-1085
[9]   THE CLASSIFICATION AND DEFINITION OF THE HYPERTENSIVE DISORDERS OF PREGNANCY [J].
DAVEY, DA ;
MACGILLIVRAY, I .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (04) :892-898
[10]   LIPOPROTEIN(A) MODULATION OF ENDOTHELIAL-CELL SURFACE FIBRINOLYSIS AND ITS POTENTIAL ROLE IN ATHEROSCLEROSIS [J].
HAJJAR, KA ;
GAVISH, D ;
BRESLOW, JL ;
NACHMAN, RL .
NATURE, 1989, 339 (6222) :303-305